Home › NDC Lookup › RxCUI directory › RxCUI 2694304

Arimoclomol 93 MG Oral Capsule — RxCUI 2694304

RxNorm drug concept · Semantic clinical drug
RxCUI 2694304 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2694304
Official nameArimoclomol 93 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asarimoclomol 93 MG (equivalent to 150 MG arimoclomol citrate) Oral Capsule
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Arimoclomol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Niemann-Pick disease type C (NPC) is a rare inherited condition where the body cannot properly move cholesterol and certain fats inside cells. Over time this damages the brain and...
  • What exactly is Niemann-Pick disease type C, and how does Miplyffa help?
  • No — Miplyffa is only approved to be used together with miglustat, not on its own. Both medicines work as a combination for treating NPC. Make sure you're taking both as your docto...
  • The most common side effects are upper respiratory infections (like colds), diarrhea, and some weight loss. These are generally manageable. What you really want to watch for — espe...
📖 Read our full Arimoclomol guide →

🕸️ Concept Web — How Arimoclomol 93 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Arimoclomol 93 MG Oral Capsule RxCUI 2694304

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Arimoclomol 2694283
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Miplyffa 2694289
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Arimoclomol Oral Capsule 2694287
    • Arimoclomol Oral Product 2694285
    • Arimoclomol Pill 2694286
    • Arimoclomol Oral Capsule [Miplyffa] 2694293
    • Miplyffa Oral Product 2694291
    • Miplyffa Pill 2694292
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Arimoclomol 93 MG SCDC · 2694303
  • Arimoclomol Oral Capsule SCDF · 2694287
  • Arimoclomol Oral Product SCDG · 2694285
  • Arimoclomol Pill SCDG · 2694286

Brand-Name Concepts

  • Arimoclomol 93 MG Oral Capsule [Miplyffa] SBD · 2694306
  • Arimoclomol 93 MG [Miplyffa] SBDC · 2694305
  • Arimoclomol Oral Capsule [Miplyffa] SBDF · 2694293
  • Miplyffa Oral Product SBDG · 2694291
  • Miplyffa Pill SBDG · 2694292
  • Miplyffa BN · 2694289

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 2694304 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72542-0124-01 1 BOTTLE in 1 CARTON (72542-124-01) / 90 CAPSULE in 1 BOTTL... MIPLYFFA Acer Therapeutics Inc. 2024-09-20
72542-0147-01 1 BOTTLE in 1 CARTON (72542-147-01) / 90 CAPSULE in 1 BOTTL... MIPLYFFA Acer Therapeutics Inc. 2024-09-20
72542-0162-01 1 BOTTLE in 1 CARTON (72542-162-01) / 90 CAPSULE in 1 BOTTL... MIPLYFFA Acer Therapeutics Inc. 2024-09-20
72542-0193-01 1 BOTTLE in 1 CARTON (72542-193-01) / 90 CAPSULE in 1 BOTTL... MIPLYFFA Acer Therapeutics Inc. 2024-09-20
Observed labelers: Acer Therapeutics Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.